Document Detail


Influence of the selective neuronal NO synthase inhibitor ARL 17477 on nitrergic neurotransmission in porcine stomach.
MedLine Citation:
PMID:  16257402     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Selective neuronal NOS (nNOS) inhibitors have been developed for possible application in cerebral ischemia and neurodegenerative disorders. To investigate the degree of interference with peripheral nNOS, the influence of the selective nNOS inhibitor ARL 17477 was studied on electrically induced nitrergic relaxations in pig gastric fundus strips and on gastric fundic compliance in conscious pig. Circular muscle strips of porcine gastric fundus were electrically stimulated (10 s trains at 4 Hz, 0.1 ms and 40 V). ARL 17477 inhibited the electrically induced relaxations in a concentration-dependent way (3x10(-6) M-10(-4) M). The inhibitory effect of ARL 17477 developed more progressively than that of N(G)-nitro-L-arginine methyl ester (L-NAME; 3x10(-4) M). In conscious pigs, instrumented with a fundic cannula, L-NAME (20 mg/kg i.v.) significantly increased mean arterial blood pressure and decreased fundic compliance in the fasted state (71+/-13 ml/mm Hg versus 185+/-37 ml/mm Hg after saline; P<0.05). ARL 17477 (3 mg/kg, i.v.) did not influence blood pressure but influenced gastric fundic volume-pressure curves in a similar way as L-NAME. Plasma concentration analysis of ARL 17477 indicated a half-life of less than 30 min in pig. ARL 17477 thus inhibits the effect of nitrergic neurons in the pig gastric fundus in vitro, leading to inhibited gastric compliance in the conscious pig. The study indicates that selective nNOS inhibitors, applied for cerebral disorders, might also interfere with neuronal nitrergic regulation of gastrointestinal motility.
Authors:
Romain A Lefebvre; Joëlle M C Dick; Sylvie Guérin; Charles-Henri Malbert
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't     Date:  2005-10-27
Journal Detail:
Title:  European journal of pharmacology     Volume:  525     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-11-28     Completed Date:  2006-02-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  143-9     Citation Subset:  IM    
Affiliation:
Heymans Institute of Pharmacology, Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, B-9000 Gent, Belgium. Romain.Lefebvre@UGent.be
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amidines / blood,  pharmacokinetics,  pharmacology*
Animals
Blood Pressure / drug effects
Compliance / drug effects
Electric Stimulation
Enzyme Inhibitors / pharmacology
Female
Gastric Fundus / drug effects*,  physiology
Male
Muscle Contraction / drug effects
Muscle, Smooth / drug effects,  physiology
NG-Nitroarginine Methyl Ester / pharmacology
Nitrergic Neurons / drug effects*,  physiology
Nitric Oxide / pharmacology
Nitric Oxide Synthase Type I / antagonists & inhibitors*
Swine
Chemical
Reg. No./Substance:
0/ARL 17477; 0/Amidines; 0/Enzyme Inhibitors; 10102-43-9/Nitric Oxide; 50903-99-6/NG-Nitroarginine Methyl Ester; EC 1.14.13.39/Nitric Oxide Synthase Type I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lysosomal enzyme activities: new potential markers for Sjögren's syndrome.
Next Document:  p16INK4A expression in cervical premalignant and malignant lesions.